Key Points
- Theresa Yanofsky, a Canopy Growth director, sold 10,434 shares on Dec. 31 at an average price of $1.13 for about $11,790, reducing her direct stake to 63,518 shares — a 14.11% decrease (SEC filing).
- Canopy Growth trades near $1.19 with a market cap of $438.46 million; it posted an EPS of ($0.01) that beat estimates but revenue missed at $47.86M, the company remains unprofitable with negative margins, and analysts' consensus rating is "Reduce".
Canopy Growth Corporation (NASDAQ:CGC - Get Free Report) Director Theresa Yanofsky sold 10,434 shares of Canopy Growth stock in a transaction dated Wednesday, December 31st. The stock was sold at an average price of $1.13, for a total transaction of $11,790.42. Following the transaction, the director directly owned 63,518 shares of the company's stock, valued at approximately $71,775.34. This represents a 14.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Canopy Growth Trading Up 4.4%
Shares of NASDAQ CGC opened at $1.19 on Friday. The business's 50 day moving average price is $1.24 and its 200-day moving average price is $1.29. The company has a market cap of $438.46 million, a price-to-earnings ratio of -0.61 and a beta of 0.40. The company has a debt-to-equity ratio of 0.31, a quick ratio of 4.23 and a current ratio of 5.50. Canopy Growth Corporation has a fifty-two week low of $0.77 and a fifty-two week high of $3.07.
Canopy Growth (NASDAQ:CGC - Get Free Report) last released its earnings results on Friday, November 7th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.10. The business had revenue of $47.86 million during the quarter, compared to the consensus estimate of $71.82 million. Canopy Growth had a negative return on equity of 61.97% and a negative net margin of 113.21%. On average, sell-side analysts expect that Canopy Growth Corporation will post -2.81 earnings per share for the current year.
Institutional Investors Weigh In On Canopy Growth
Institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC grew its stake in Canopy Growth by 196.9% in the third quarter. Millennium Management LLC now owns 3,137,696 shares of the company's stock valued at $4,579,000 after purchasing an additional 2,080,994 shares during the last quarter. Two Sigma Investments LP bought a new stake in shares of Canopy Growth in the 3rd quarter valued at about $1,767,000. Tidal Investments LLC boosted its holdings in shares of Canopy Growth by 31.5% in the 2nd quarter. Tidal Investments LLC now owns 5,033,793 shares of the company's stock valued at $6,141,000 after buying an additional 1,204,530 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Canopy Growth by 10,308.3% in the 1st quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company's stock worth $882,000 after buying an additional 960,218 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new position in shares of Canopy Growth during the 3rd quarter worth approximately $815,000. Institutional investors own 3.33% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have commented on the company. Benchmark raised Canopy Growth from a "sell" rating to a "hold" rating in a research report on Monday, November 10th. Weiss Ratings restated a "sell (e+)" rating on shares of Canopy Growth in a research note on Wednesday, October 8th. Alliance Global Partners reaffirmed a "neutral" rating on shares of Canopy Growth in a research note on Monday, December 15th. Finally, Wall Street Zen raised shares of Canopy Growth from a "sell" rating to a "hold" rating in a research report on Saturday, November 8th. Three research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, Canopy Growth currently has an average rating of "Reduce".
View Our Latest Stock Analysis on CGC
Canopy Growth Company Profile
(
Get Free Report)
Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.
The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
